Obada A. H.
- Country
- Germany
- Department
- Parexel Early Phase Unit Berlin, 101
Research Overview
- Evaluation of the Pharmacokinetic Interaction of Gemfibrozil, Itraconazole, and Phenytoin on IPN60250 Plasma Levels in Healthy Adults
- Safety and Tolerability of Intravenous and Subcutaneous AZD1163 in Rheumatoid Arthritis: A Placebo-Controlled Study in Healthy Volunteers
- Pharmacokinetics, Immunogenicity, and Safety Comparison of PB016 and US-Licensed Vedolizumab in Healthy Volunteers After Subcutaneous Administration
Data & Insights
Has run more than one trial at 1 of 1 partner site.
Specializations
Drug Interaction Studies
The investigator focuses on understanding pharmacokinetic interactions between different therapeutic agents, particularly studying how common medications affect novel compounds in the bloodstream.
- Drug-drug interactions
- Pharmacokinetic analysis
- Blood level monitoring
Special attention is given to investigating interactions with gemfibrozil, itraconazole, and phenytoin in clinical settings.
Rheumatology Research
The investigator conducts research in the field of rheumatoid arthritis, evaluating novel therapeutic approaches through both intravenous and subcutaneous administration routes.
- Autoimmune disorders
- Novel therapeutic agents
- Drug delivery methods
Research encompasses safety and tolerability assessments of new therapeutic compounds for inflammatory conditions.
Clinical Pharmacology
The investigator specializes in conducting healthy volunteer studies to evaluate the safety profiles and biological effects of investigational medications.
- Safety assessment
- Tolerability evaluation
- Administration route comparison
Focus includes comparative analysis of different drug administration routes and their impact on therapeutic outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.